Cytosorbents (CTSO) Total Debt Growth (3y) (2016 - 2026)
Powered by 
Analysis
Cytosorbents (CTSO) Total Debt Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -10.56% |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | 50.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.86% |
| Mar 31, 2026 | 50.14% |
| Dec 31, 2025 | 49.38% |
| Sep 30, 2023 | -37.76% |
| Jun 30, 2023 | -38.69% |
| Mar 31, 2023 | -36.16% |
| Dec 31, 2022 | -33.13% |
| Sep 30, 2020 | 23.34% |
| Jun 30, 2020 | 22.20% |
| Mar 31, 2020 | 46.08% |
| Dec 31, 2019 | 50.43% |
| Sep 30, 2019 | 50.58% |
| Jun 30, 2019 | 29.35% |
| Jun 30, 2017 | 156.29% |
| Mar 31, 2017 | 52.93% |
| Dec 31, 2016 | 44.02% |
| Sep 30, 2016 | 50.40% |
| Jun 30, 2016 | 76.32% |